We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$54.7B
AUM Growth
-$333M
Cap. Flow
-$906M
Cap. Flow %
-1.66%
Top 10 Hldgs %
14.84%
Holding
1,599
New
74
Increased
554
Reduced
585
Closed
78

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$114M
2
ORCL icon
Oracle
ORCL
+$96.1M
3
ALL icon
Allstate
ALL
+$88.6M
4
QCOM icon
Qualcomm
QCOM
+$88.3M
5
MRSH
Marsh
MRSH
+$73.9M

Sector Composition

Rank Sector Weight
1 Healthcare 17.55%
2 Financials 15.04%
3 Technology 12.33%
4 Energy 9.55%
5 Industrials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TUR icon
401
iShares MSCI Turkey ETF
TUR
$206M
$24.3M 0.04%
584,400
+20,000
+4% +$794K
MATX icon
402
Matsons
MATX
$6.43B
$24.1M 0.04%
803,809
-61,906
-7% -$1.9M
PH icon
403
Parker-Hannifin
PH
$125B
$24.1M 0.04%
150,509
+4,067
+3% +$644K
RJF icon
404
Raymond James Financial
RJF
$32.3B
$23.9M 0.04%
446,649
-18,674
-4% -$940K
ATKR icon
405
Atkore
ATKR
$2.46B
$23.8M 0.04%
+1,054,424
New +$24.8M
QTS
406
DELISTED
QTS REALTY TRUST, INC.
QTS
$23.6M 0.04%
450,558
-92,962
-17% -$4.81M
URI icon
407
United Rentals
URI
$70.9B
$23.5M 0.04%
208,873
-130,876
-39% -$14.6M
JCI icon
408
Johnson Controls International
JCI
$87.6B
$23.5M 0.04%
542,522
+28,826
+6% +$1.21M
MYRG icon
409
MYR Group
MYRG
$6.25B
$23.5M 0.04%
757,075
+71,376
+10% +$2.45M
C icon
410
Citigroup
C
$222B
$23.4M 0.04%
350,575
+7,681
+2% +$471K
RGEN icon
411
Repligen
RGEN
$7.54B
$23.2M 0.04%
559,201
+81,194
+17% +$3.09M
BDC icon
412
Belden
BDC
$4.02B
$23.1M 0.04%
+306,011
New +$21.9M
TVTX icon
413
Travere Therapeutics
TVTX
$5.3B
$23.1M 0.04%
1,188,819
+172,389
+17% +$3.13M
HZO icon
414
MarineMax
HZO
$732M
$23M 0.04%
1,177,725
+56,596
+5% +$1.11M
UBSI icon
415
United Bankshares
UBSI
$6.49B
$22.9M 0.04%
+583,611
New +$23.2M
SQM icon
416
Sociedad Química y Minera de Chile
SQM
$19.8B
$22.8M 0.04%
690,695
-98,600
-12% -$3.46M
TECH icon
417
Bio-Techne
TECH
$11.2B
$22.7M 0.04%
773,988
-943,112
-55% -$25.8M
WW
418
DELISTED
WW International
WW
$22.6M 0.04%
+675,417
New +$16.3M
TRV icon
419
Travelers Companies
TRV
$80.2B
$22.5M 0.04%
177,902
-5,790
-3% -$713K
BXP icon
420
Boston Properties
BXP
$10.9B
$22.5M 0.04%
182,765
+4,693
+3% +$593K
SRCI
421
DELISTED
SRC Energy Inc
SRCI
$22.5M 0.04%
3,336,125
+822,153
+33% +$6.04M
COHR icon
422
Coherent
COHR
$57B
$22.3M 0.04%
650,644
+217,946
+50% +$7.06M
KFRC icon
423
Kforce
KFRC
$1B
$22.3M 0.04%
1,136,060
+164,268
+17% +$3.3M
ESS icon
424
Essex Property Trust
ESS
$18.9B
$22.2M 0.04%
86,143
-7,240
-8% -$1.82M
NOW icon
425
ServiceNow
NOW
$99.6B
$22M 0.04%
1,036,570
-100,535
-9% -$1.97M

Similar funds

Macquarie Group's Q2 2017 Portfolio in Review

As of Q2 2017, Macquarie Group held 1,599 positions worth $54.7B, down 0.61% from $55B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q2 2017 filing shows 74 new, 554 increased, 585 reduced and 78 closed positions. Its largest new stake was Altaba Inc: 830,118 shares worth $45.2M. The largest sale was Quest Diagnostics, an estimated $114M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q2 2017 buy was Altaba Inc: 830,118 shares worth $45.2M.
  • Macquarie Group added most to Marathon Oil Corporation in Q2 2017, an estimated $399M increase.
  • Macquarie Group's biggest Q2 2017 reduction was Quest Diagnostics, cutting an estimated $114M.
  • Macquarie Group fully exited Syngenta Ag in Q2 2017, selling an estimated $69.7M.
  • Macquarie Group's ten largest holdings make up 15% of its $54.7B portfolio in Q2 2017.
  • Macquarie Group opened 74 new positions and closed 78 in Q2 2017.
  • Macquarie Group's portfolio value fell 0.61% quarter-over-quarter to $54.7B.

Based on Macquarie Group's 13F filing for Q2 2017, filed 14 Aug 2017.